Management of acoustic neuromas with fractionated stereotactic radiotherapy (FSRT): Long-term results in 106 patients treated in a single institution

International Journal of Radiation Oncology Biology Physics

Volumn 63, Issue 1, 2005, Pages 75-81

  Combs, Stephanie E ^a,b   Volk, Sigrid ^b   Schulz Ertner, Daniela ^a,b   Huber, Peter E ^a,b   Thilmann, Christoph ^a,b   Debus, Jürgen ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Fractionated stereotactic radiotherapy; Hearing preservation; Local control; Toxicity; Vestibular schwannoma

Indexed keywords

HEARING AIDS; NEUROLOGY; PATIENT TREATMENT; TOXICITY; TUMORS;

FRACTIONATED STEREOTACTIC RADIOTHERAPY; HEARING PRESERVATION; LOCAL CONTROL; VESTIBULAR SCHWANNOMA;

RADIOTHERAPY;

ACOUSTIC NEURINOMA; ADULT; AGED; ARTICLE; CANCER CONTROL; CRANIAL NEUROPATHY; DISEASE ASSOCIATION; FACIAL NERVE DISEASE; FEMALE; FOLLOW UP; HEARING ACUITY; HEARING IMPAIRMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROFIBROMATOSIS; PRIORITY JOURNAL; RADIATION DOSE; TREATMENT OUTCOME; TRIGEMINAL NERVE DISEASE; TUMOR VOLUME; ADOLESCENT; HEARING; METHODOLOGY; MIDDLE AGED; NEUROMA; RADIATION DOSE FRACTIONATION; RADIOSURGERY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HEARING; HUMANS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 2; NEUROMA, ACOUSTIC; RADIOSURGERY; TREATMENT OUTCOME; TRIGEMINAL NERVE DISEASES;

EID: 26944500878     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2005.01.055     Document Type: Article

References (49)

1. Neely JG, Hough JV. Histologic findings in two very small intracanalicular solitary schwannomas of the eighth nerve: II. "Onion bulbs." Am J Otol 1988;9:216-221.
2. Hardy DG, Macfarlane R, Baguley D, et al. Surgery for acoustic neurinoma. An analysis of 100 translabyrinthine operations. J Neurosurg 1989;71:799-804.
3. Thomsen J, Zilstorff K, Tos M. Acoustic neuromas (diagnostic value of testing the function of the trigeminal nerve, the cerebellum, and optokinetic nystagmus). J Laryngol Otol 1983;97:801-812.
4. Wiegand DA, Fickel V. Acoustic neuroma-the patient's perspective: Subjective assessment of symptoms, diagnosis, therapy, and outcome in 541 patients. Laryngoscope 1989;99:179-187.
5. Samii M, Matthies C. Management of 1000 vestibular schwannomas (acoustic neuromas): Surgical management and results with an emphasis on complications and how to avoid them. Neurosurgery 1997;40:11-21.
6. Sluyter S, Graamans K, Tulleken CA, et al. Analysis of the results obtained in 120 patients with large acoustic neuromas surgically treated via the translabyrinthine-transtentorial approach. J Neurosurg 2001;94:61-66.
7. Pitts LH, Jackler RK. Treatment of acoustic neuromas. N Engl J Med 1998;339:1471-1473.
8. Gormley WB, Sekhar LN, Wright DC, et al. Acoustic neuromas: Results of current surgical management. Neurosurgery 1997;41:50-58.
9. Karpinos M, Teh BS, Zeck O, et al. Treatment of acoustic neuroma: Stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 2002;54:1410-1421.
10. Staecker H, Nadol JB, Jr, Ojeman R, et al. Hearing preservation in acoustic neuroma surgery: Middle fossa versus retrosigmoid approach. Am J Otol 2000;21:399-404.
11. Arriaga MA, Chen DA, Fukushima T. Individualizing hearing preservation in acoustic neuroma surgery. Laryngoscope 1997;107:1043-1047.
12. Leksell L. A note on the treatment of acoustic tumours. Acta Chir Scand 1971;137:763-765.
13. Noren G, Greitz D, Hirsch A, Lax I. Gamma knife surgery in acoustic tumours. Acta Neurochir Suppl (Wien) 1993;58:104-107.
14. Ito K, Kurita H, Sugasawa K, et al. Analyses of neurootological complications after radiosurgery for acoustic neurinomas. Int J Radiat Oncol Biol Phys 1997;39:983-988.
15. Thomassin JM, Epron JP, Regis J, et al. Preservation of hearing in acoustic neuromas treated by gamma knife surgery. Stereotact Funct Neurosurg 1998;70(Suppl. 1):74-79.
16. Flickinger JC, Kondziolka D, Lunsford LD. Clinical applications of stereotactic radiosurgery. Cancer Treat Res 1998;93:283-297.
17. Andrews DW, Suarez O, Goldman HW, et al. Stereotactic radiosurgery and fractionated stereotactic radiotherapy for the treatment of acoustic schwannomas: Comparative observations of 125 patients treated at one institution. Int J Radiat Oncol Biol Phys 2001;50:1265-1278.
18. Foote KD, Friedman WA, Buatti JM, et al. Analysis of risk factors associated with radiosurgery for vestibular schwannoma. J Neurosurg 2001;95:440-449.
19. Suh JH, Barnett GH, Sohn JW, et al. Results of linear accelerator-based stereotactic radiosurgery for recurrent and newly diagnosed acoustic neuromas. Int J Cancer 2000;90:145-151.
20. Mendenhall WM, Friedman WA, Buatti JM, et al. Preliminary results of linear accelerator radiosurgery for acoustic schwannomas. J Neurosurg 1996;85:1013-1019.
21. Meijer OW, Wolbers JG, Baayen JC, et al. Fractionated stereotactic radiation therapy and single high-dose radiosurgery for acoustic neuroma: Early results of a prospective clinical study. Int J Radiat Oncol Biol Phys 2000;46:45-49.
22. Spiegelmann R, Lidar Z, Gofman J, et al. Linear accelerator radiosurgery for vestibular schwannoma. J Neurosurg 2001;94:7-13.
23. Poen JC, Golby AJ, Forster KM, et al. Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: A preliminary report. Neurosurgery 1999;45:1299-1305.
24. Varlotto JM, Shrieve DC, Alexander E III, et al. Fractionated stereotactic radiotherapy for the treatment of acoustic neuromas: Preliminary results. Int J Radiat Oncol Biol Phys 1996;36:141-145.
25. Szumacher E, Schwartz ML, Tsao M, et al. Fractionated stereotactic radiotherapy for the treatment of vestibular schwannomas: Combined experience of the Toronto-Sunnybrook Regional Cancer Centre and the Princess Margaret Hospital. Int J Radiat Oncol Biol Phys 2002;53:987-991.
26. Fuss M, Debus J, Lohr F, et al. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas. Int J Radiat Oncol Biol Phys 2000;48:1381-1387.
27. Lederman G, Lowry J, Wertheim S, et al. Acoustic neuroma: Potential benefits of fractionated stereotactic radiosurgery. Stereotact Funct Neurosurg 1997;69:175-182.
28. Song DY, Williams JA. Fractionated stereotactic radiosurgery for treatment of acoustic neuromas. Stereotact Funct Neurosurg 1999;73:45-49.
29. Menke M, Hirschfeld F, Mack T, et al. Photogrammetric accuracy measurements of head holder systems used for fractionated radiotherapy. Int J Radiat Oncol Biol Phys 1994;29:1147-1155.
30. Karger CP, Hartmann GH, Heeg P, et al. A method for determining the alignment accuracy of the treatment table axis at an isocentric irradiation facility. Phys Med Biol 2001;46:N19-N26.
31. Debus J, Kocagoncu KO, Hoss A, et al. Fractionated stereotactic radiotherapy (FSRT) for optic glioma. Int J Radiat Oncol Biol Phys 1999;44:243-248.
32. Gademann G, Schlegel W, Debus J, et al. Fractionated stereotactically guided radiotherapy of head and neck tumors: A report on clinical use of a new system in 195 cases. Radiother Oncol 1993;29:205-213.
33. Schulz-Ertner D, Debus J, Lohr F, et al. Fractionated stereotactic conformal radiation therapy of brain stem gliomas: Outcome and prognostic factors. Radiother Oncol 2000;57:215-223.
34. Schad LR, Boesecke R, Schlegel W, et al. Three dimensional image correlation of CT, MR, and PET studies in radiotherapy treatment planning of brain tumors. J Comput Assist Tomogr 1987;11:948-954.
35. Schad LR, Bluml S, Hawighorst H, et al. Radiosurgical treatment planning of brain metastases based on a fast, three-dimensional MR imaging technique. Magn Reson Imaging 1994;12:811-819.
36. Clark TG, Bradburn MJ, Love SB, et al. Survival analysis part I: Basic concepts and first analyses. Br J Cancer 2003;89:232-238.
37. Kondziolka D, Lunsford LD, Flickinger JC. Acoustic tumors: Operation versus radiation-making sense of opposing viewpoints. Part II. Acoustic neuromas: Sorting out management options. Clin Neurosurg 2003;50:313-328.
38. Pollock BE, Lunsford LD, Kondziolka D, et al. Outcome analysis of acoustic neuroma management: A comparison of microsurgery and stereotactic radiosurgery. Neurosurgery 1995;36:215-224.
39. Shelton C, Brackmann DE, House WF, et al. Acoustic tumor surgery. Prognostic factors in hearing conversation. Arch Otolaryngol Head Neck Surg 1989;115:1213-1216.
40. Post KD, Eisenberg MB, Catalano PJ. Hearing preservation in vestibular schwannoma surgery: What factors influence outcome? J Neurosurg 1995;83:191-196.
41. Meijer OW, Vandertop WP, Baayen JC, et al. Single-fraction vs. fractionated linac-based stereotactic radiosurgery for vestibular schwannoma: A single-institution study. Int J Radiat Oncol Biol Phys 2003;56:1390-1396.
42. Meeks SL, Buatti JM, Foote KD, et al. Calculation of cranial nerve complication probability for acoustic neuroma radiosurgery. Int J Radiat Oncol Biol Phys 2000;47:597-602.
43. Flickinger JC, Kondziolka D, Lunsford LD. Dose and diameter relationships for facial, trigeminal, and acoustic neuropathies following acoustic neuroma radiosurgery. Radiother Oncol 1996;41:215-219.
44. Miller RC, Foote RL, Coffey RJ, et al. Decrease in cranial nerve complications after radiosurgery for acoustic neuromas: A prospective study of dose and volume. Int J Radiat Oncol Biol Phys 1999;43:305-311.
45. Linskey ME, Flickinger JC, Lunsford LD. Cranial nerve length predicts the risk of delayed facial and trigeminal neuropathies after acoustic tumor stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 1993;25:227-233.
46. Foote KD, Friedman WA, Buatti JM, et al. Linear accelerator radiosurgery in brain tumor management. Neurosurg Clin North Am 1999;10:203-242.
47. Kondziolka D, Lunsford LD, McLaughlin MR, et al. Long-term outcomes after radiosurgery for acoustic neuromas. N Engl J Med 1998;339:1426-1433.
48. Lederman G, Arbit E, Odaimi M, et al. Recurrent glioblastoma multiforme: Potential benefits using fractionated stereotactic radiotherapy and concurrent Taxol. Stereotact Funct Neurosurg 1997;69:162-174.
49. Shirato H, Sakamoto T, Sawamura Y, et al. Comparison between observation policy and fractionated stereotactic radiotherapy (SRT) as an initial management for vestibular schwannoma. Int J Radiat Oncol Biol Phys 1999;44:545-550.